Kaneka Europe Holding Company NV was established in 2015 to structurize Kaneka’s business planning strategy and strengthen governance in Europe, the Middle East, and Africa (EMEA region). Moreover, the holding company supports the business of Kaneka and local corporations and provides management and structural support for the growth of the business portfolio in the EMEA region.
Corporate profile
Name
KANEKA EUROPE HOLDING COMPANY NV
Year of establishment
2015
Head office
Lenneke Marelaan 4, 1932 Zaventem, Belgium
Activity
Planning business strategy and strengthening governance in Europe, the Middle East and Africa (EMEA), supporting business of Kaneka and local corporations in EMEA.
Kaneka group companies structured within the Kaneka Europe Holding Company
Belgium
Kaneka Belgium NV, Head office & plant: Westerlo-Oevel, Office: Brussels
Manufacturing, R&D and sales of performance polymers, and expandable foam techs resins.
Marketing, sales and R&D of Green Planet™ biodegradable polymers.
Marketing and sales of biosurfactants.
Kaneka Medical Europe NV, Brussels
Marketing and sales of functional food ingredients (Ubiquinol Q10) and intermediates (Brussels).
Marketing and sales of medical devices (German branch Eschborn).
Kaneka Eurogentec S.A., Liege
Kaneka Eurogentec is a biotechnology company recognized as one of the major suppliers in the field of genomics and proteomics as well as a trusted US FDA inspected Contract Development and Manufacturing Organization (CDMO) for the bio-production of pharmaceuticals vaccines and medicines.
Kaneka Eurogentec is also a leading company in large scale production of GMP DNA Plasmid for DNA vaccines and starting materials for vector-based gene medicines.